相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Renata Micha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Increased Prevalence of Metabolic Syndrome Associated with Rheumatoid Arthritis in Patients without Clinical Cardiovascular Disease
Cynthia S. Crowson et al.
JOURNAL OF RHEUMATOLOGY (2011)
The Influence of Rheumatoid Arthritis Disease Characteristics on Heart Failure
Elena Myasoedova et al.
JOURNAL OF RHEUMATOLOGY (2011)
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of Long-Term Disease-Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis
M. Turiel et al.
CARDIOVASCULAR THERAPEUTICS (2010)
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2010)
Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment
Gorica G. Ristic et al.
RHEUMATOLOGY (2010)
An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
Michael E. Farkouh et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis
B. J. Radovits et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis
Antonios Stavropoulos-Kalinoglou et al.
CLINICAL RHEUMATOLOGY (2009)
The Effects of METhotrexate Therapy on the Physical Capacity of Patients With ISchemic Heart Failure: A Randomized Double-Blind, Placebo-Controlled Trial (METIS Trial)
Daniel Medeiros Moreira et al.
JOURNAL OF CARDIAC FAILURE (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60-more than just an anti-inflammatory effect? A cross sectional study
Tracey E. Toms et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Atheroprotective Effects of Methotrexate on Reverse Cholesterol Transport Proteins and Foam Cell Transformation in Human THP-1 Monocyte/Macrophages
Allison B. Reiss et al.
ARTHRITIS AND RHEUMATISM (2008)
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
John M. Davis et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of Body Composition With Disability in Rheumatoid Arthritis: Impact of Appendicular Fat and Lean Tissue Mass
Jon T. Giles et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
J. Antonio Avina-Zubieta et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis
Cecilia P. Chung et al.
ATHEROSCLEROSIS (2008)
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006
Marc C. Hochberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus
Abraham Zonana-Nacach et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients
Athanasios N. Georgiadis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Antonio Naranjo et al.
ARTHRITIS RESEARCH & THERAPY (2008)
The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men
C. J. Edwards et al.
HEART (2007)
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
Henrike van Dongen et al.
ARTHRITIS AND RHEUMATISM (2007)
Glucocorticoids and cardiovascular events in rheumatoid arthritis - A population-based cohort study
John M. Davis et al.
ARTHRITIS AND RHEUMATISM (2007)
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study
S. A. Karvounaris et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Methotrexate pharmacogenomics
J. M. Kremer
ANNALS OF THE RHEUMATIC DISEASES (2006)
Antirheumatic drug use and the risk of acute myocardial infarction
Samy Suissa et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production
Y. Morita et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
MIF:: a new cytokine link between rheumatoid arthritis and atherosclerosis
EF Morand et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis
MA Lopez-Olivo et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Left ventricular systolic dysfunction in rheumatoid disease - An unrecognized burden?
GS Bhatia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome
GA Bray et al.
ENDOCRINE (2006)
Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs
WW Bolten
ANNALS OF THE RHEUMATIC DISEASES (2006)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Rheumatoid arthritis: A disease associated with accelerated atherogenesis
MA Gonzalez-Gay et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
S Bernatsky et al.
RHEUMATOLOGY (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis
S Prodanowich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
The risk of congestive heart failure in rheumatoid arthritis - A population-based study over 46 years
PJ Nicola et al.
ARTHRITIS AND RHEUMATISM (2005)
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
VPK Nell et al.
RHEUMATOLOGY (2004)
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
PM Ridker et al.
CIRCULATION (2004)
Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?
S Wållberg-Jonsson et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar et al.
CIRCULATION (2003)
The metabolic syndrome - More than the sum of its parts?
MP Reilly et al.
CIRCULATION (2003)
Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis
K Schroecksnadel et al.
CLINICA CHIMICA ACTA (2003)
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: A prospective study
YB Park et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Mortality in early inflammatory polyarthritis - Cardiovascular mortality is increased in seropositive patients
NJ Goodson et al.
ARTHRITIS AND RHEUMATISM (2002)
Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis
Y Kumeda et al.
ARTHRITIS AND RHEUMATISM (2002)
Association between naproxen use and protection against acute myocardial infarction
E Rahme et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Accelerated atherosclerosis - An extraarticular feature of rheumatoid arthritis?
S Van Doornum et al.
ARTHRITIS AND RHEUMATISM (2002)
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
T Möttönen et al.
ARTHRITIS AND RHEUMATISM (2002)
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: Comparison of two cohorts who received different treatment strategies
LR Lard et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis
A McEntegart et al.
RHEUMATOLOGY (2001)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
分享论文
